The price of apomorphine can vary significantly depending on several factors, including the formulation, dosage, location of purchase, and insurance coverage. Apomorphine is available in different forms, such as sublingual films and injectable solutions.
How much does apomorphine typically cost?
For example, a prescription for apomorphine sublingual films, like KYNMOBI, can range from several hundred to over a thousand dollars for a month's supply, before insurance. The exact out-of-pocket cost for patients will depend on their insurance plan's formulary, deductible, and co-payment or co-insurance structure. Assistance programs may be available from manufacturers or third-party organizations to help eligible patients reduce their costs.
What factors influence apomorphine pricing?
Pricing is influenced by the drug's development costs, manufacturing expenses, market demand, and patent status. Competition from other treatments for Parkinson's disease can also play a role. For individuals without insurance, or those with high-deductible plans, the retail price can be substantial.
When does apomorphine patent exclusivity expire?
The patent protection for apomorphine and its various formulations is crucial to its pricing and market exclusivity. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can indicate when generic versions might become available, potentially leading to price reductions. Information on specific patents for apomorphine formulations would be detailed on such specialized databases.
Can I get financial assistance for apomorphine?
Patients struggling with the cost of apomorphine may be eligible for manufacturer-sponsored patient assistance programs. These programs often provide discounts or free medication to individuals who meet certain financial and eligibility criteria. Additionally, non-profit organizations and foundations focused on Parkinson's disease may offer financial aid or resources to help manage medication costs.